Topical delivery of Vismodegib using fourth-generation PAMAM dendrimers: a potential treatment for Kaposi's sarcoma.
- DOI
- 10.1016/j.ijpharm.2026.126789
- Published
- 2026 Apr 25
- Container
- International journal of pharmaceutics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ijpharm.2026.126789,
title = {Topical delivery of Vismodegib using fourth-generation PAMAM dendrimers: a potential treatment for Kaposi's sarcoma.},
author = {Ybarra DE and Barraza LF and De Francesco PN and Valle Alonso SD and Montanari J and Alvira FC},
year = {2026},
journal = {International journal of pharmaceutics},
doi = {10.1016/j.ijpharm.2026.126789},
url = {https://doi.org/10.1016/j.ijpharm.2026.126789}
}RIS
TY - JOUR TI - Topical delivery of Vismodegib using fourth-generation PAMAM dendrimers: a potential treatment for Kaposi's sarcoma. AU - Ybarra DE AU - Barraza LF AU - De Francesco PN AU - Valle Alonso SD AU - Montanari J AU - Alvira FC PY - 2026 JO - International journal of pharmaceutics DO - 10.1016/j.ijpharm.2026.126789 UR - https://doi.org/10.1016/j.ijpharm.2026.126789 ER -
APA
DE, Y., LF, B., PN, D. F., SD, V. A., J, M., & FC, A. (2026). Topical delivery of Vismodegib using fourth-generation PAMAM dendrimers: a potential treatment for Kaposi's sarcoma.. International journal of pharmaceutics. https://doi.org/10.1016/j.ijpharm.2026.126789
Source records
- pubmed · retrieved 2026-09-26T19:21:23.314Z